IDEAYA Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors: https://lnkd.in/gq9JmmuU | IDEAYA Biosciences posted on the topic

IDEAYA gets FDA IND clearance for DLL3 ADC in solid tumors

View organization page for IDEAYA Biosciences

17,446 followers

3mo

IDEAYA Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors: https://lnkd.in/gq9JmmuU

3 Comments

Georghia Michael, PhD

Strategic Narratives That De-Risk Decisions | Biotech · Pharma · Advocacy | Messaging Frameworks · Stakeholder Alignment · Advisory | Co-Founder @OdysseaBio

3mo

Congratulations!

Katrina Mack-Oteyza

Full Time In-House, Hybrid or Remote in La Jolla San Diego. Director/Associate Director Operations. Senior CTM, PM positions Full Time employee w/ benefits, or 1099/W-2 Consultant!

3mo

wonderful news

IDEAYA gets FDA IND clearance for DLL3 ADC in solid tumors

Explore topics